Bristol Historical Balance Sheet

BMY Stock

USD 41.48 0.60 1.47%

Trend analysis of Bristol Myers Squibb balance sheet accounts such as Short Long Term Debt Total of 43.5 B, Other Current Liabilities of 12.1 B or Total Current Liabilities of 23.4 B provides information on Bristol Myers' total assets, liabilities, and equity, which is the actual value of Bristol Myers Squibb to its prevalent stockholders. By breaking down trends over time using Bristol Myers balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Bristol Myers Squibb latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bristol Myers Squibb is a good buy for the upcoming year.

Bristol Myers Inventory

1.86 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About Bristol Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Bristol Myers Squibb at a specified time, usually calculated after every quarter, six months, or one year. Bristol Myers Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Bristol Myers and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Bristol currently owns. An asset can also be divided into two categories, current and non-current.

Bristol Myers Balance Sheet Chart

At this time, Bristol Myers' Good Will is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 99.9 B in 2024, whereas Total Stockholder Equity is likely to drop slightly above 15 B in 2024.

Total Assets Short Long Term Debt Total Total Current Liabilities Total Stockholder Equity Other Current Assets Other Stockholder Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Bristol Myers assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Bristol Myers Squibb books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Bristol Myers balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Bristol Myers Squibb are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most accounts from Bristol Myers' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Bristol Myers Squibb current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	45.6B	40.7B	41.5B	43.5B
Total Assets	109.3B	96.8B	95.2B	99.9B

Short Long Term Debt Total Total Assets

Bristol Myers balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock Total Equity
Total Assets		0.98	0.81	0.93	0.89	0.78	0.98	-0.07	0.9	0.99	0.52	0.83	0.76	0.97	0.45	0.99	0.82	-0.16	0.88	0.99	0.7	0.94	0.85	0.96	0.6	0.88
Short Long Term Debt Total	0.98		0.78	0.92	0.84	0.79	1.0	-0.16	0.94	0.97	0.38	0.88	0.82	0.98	0.52	0.99	0.76	-0.24	0.89	0.99	0.76	0.95	0.89	0.95	0.57	0.91
Other Current Liab	0.81	0.78		0.95	0.55	0.69	0.81	-0.1	0.63	0.77	0.64	0.55	0.77	0.81	0.39	0.76	0.52	0.1	0.6	0.83	0.77	0.87	0.67	0.65	0.62	0.73
Total Current Liabilities	0.93	0.92	0.95		0.7	0.8	0.93	-0.07	0.81	0.89	0.52	0.75	0.88	0.95	0.41	0.9	0.66	-0.04	0.73	0.94	0.87	0.97	0.84	0.8	0.66	0.85
Total Stockholder Equity	0.89	0.84	0.55	0.7		0.75	0.84	0.13	0.79	0.91	0.41	0.73	0.5	0.82	0.44	0.88	0.9	-0.14	0.82	0.85	0.43	0.76	0.73	0.93	0.62	0.81
Property Plant And Equipment Net	0.78	0.79	0.69	0.8	0.75		0.79	0.28	0.73	0.76	0.19	0.7	0.77	0.84	0.41	0.78	0.64	-0.13	0.53	0.8	0.75	0.79	0.78	0.7	0.85	0.85
Net Debt	0.98	1.0	0.81	0.93	0.84	0.79		-0.17	0.9	0.98	0.42	0.83	0.82	0.98	0.52	0.99	0.77	-0.21	0.89	0.99	0.76	0.93	0.89	0.95	0.56	0.91
Retained Earnings	-0.07	-0.16	-0.1	-0.07	0.13	0.28	-0.17		-0.12	-0.07	-0.11	-0.07	-0.11	-0.03	-0.62	-0.12	0.17	0.35	-0.45	-0.11	-0.06	-0.05	-0.16	-0.13	0.44	-0.14
Cash	0.9	0.94	0.63	0.81	0.79	0.73	0.9	-0.12		0.87	0.21	0.98	0.78	0.9	0.48	0.92	0.66	-0.32	0.83	0.91	0.69	0.91	0.85	0.87	0.57	0.84
Non Current Assets Total	0.99	0.97	0.77	0.89	0.91	0.76	0.98	-0.07	0.87		0.53	0.8	0.71	0.95	0.46	0.99	0.84	-0.19	0.89	0.98	0.65	0.91	0.83	0.98	0.57	0.86
Non Currrent Assets Other	0.52	0.38	0.64	0.52	0.41	0.19	0.42	-0.11	0.21	0.53		0.12	0.16	0.38	0.18	0.45	0.49	0.12	0.44	0.48	0.18	0.45	0.18	0.45	0.21	0.35
Cash And Short Term Investments	0.83	0.88	0.55	0.75	0.73	0.7	0.83	-0.07	0.98	0.8	0.12		0.76	0.84	0.41	0.85	0.6	-0.37	0.74	0.84	0.67	0.87	0.8	0.8	0.58	0.78
Net Receivables	0.76	0.82	0.77	0.88	0.5	0.77	0.82	-0.11	0.78	0.71	0.16	0.76		0.88	0.35	0.76	0.48	-0.29	0.58	0.8	0.97	0.86	0.87	0.62	0.53	0.8
Good Will	0.97	0.98	0.81	0.95	0.82	0.84	0.98	-0.03	0.9	0.95	0.38	0.84	0.88		0.4	0.97	0.78	-0.19	0.81	0.98	0.83	0.95	0.9	0.9	0.63	0.89
Common Stock Shares Outstanding	0.45	0.52	0.39	0.41	0.44	0.41	0.52	-0.62	0.48	0.46	0.18	0.41	0.35	0.4		0.5	0.2	-0.34	0.69	0.48	0.29	0.4	0.52	0.5	0.27	0.64
Non Current Liabilities Total	0.99	0.99	0.76	0.9	0.88	0.78	0.99	-0.12	0.92	0.99	0.45	0.85	0.76	0.97	0.5		0.8	-0.22	0.9	0.99	0.69	0.93	0.86	0.97	0.58	0.88
Inventory	0.82	0.76	0.52	0.66	0.9	0.64	0.77	0.17	0.66	0.84	0.49	0.6	0.48	0.78	0.2	0.8		-0.07	0.72	0.78	0.45	0.69	0.65	0.86	0.52	0.75
Other Current Assets	-0.16	-0.24	0.1	-0.04	-0.14	-0.13	-0.21	0.35	-0.32	-0.19	0.12	-0.37	-0.29	-0.19	-0.34	-0.22	-0.07		-0.33	-0.18	-0.19	-0.07	-0.32	-0.24	0.15	-0.26
Other Stockholder Equity	0.88	0.89	0.6	0.73	0.82	0.53	0.89	-0.45	0.83	0.89	0.44	0.74	0.58	0.81	0.69	0.9	0.72	-0.33		0.87	0.49	0.77	0.78	0.94	0.3	0.81
Total Liab	0.99	0.99	0.83	0.94	0.85	0.8	0.99	-0.11	0.91	0.98	0.48	0.84	0.8	0.98	0.48	0.99	0.78	-0.18	0.87		0.75	0.96	0.87	0.95	0.61	0.89
Property Plant And Equipment Gross	0.7	0.76	0.77	0.87	0.43	0.75	0.76	-0.06	0.69	0.65	0.18	0.67	0.97	0.83	0.29	0.69	0.45	-0.19	0.49	0.75		0.82	0.83	0.55	0.56	0.75
Total Current Assets	0.94	0.95	0.87	0.97	0.76	0.79	0.93	-0.05	0.91	0.91	0.45	0.87	0.86	0.95	0.4	0.93	0.69	-0.07	0.77	0.96	0.82		0.85	0.84	0.68	0.86
Short Term Debt	0.85	0.89	0.67	0.84	0.73	0.78	0.89	-0.16	0.85	0.83	0.18	0.8	0.87	0.9	0.52	0.86	0.65	-0.32	0.78	0.87	0.83	0.85		0.82	0.53	0.84
Intangible Assets	0.96	0.95	0.65	0.8	0.93	0.7	0.95	-0.13	0.87	0.98	0.45	0.8	0.62	0.9	0.5	0.97	0.86	-0.24	0.94	0.95	0.55	0.84	0.82		0.5	0.83
Accounts Payable	0.6	0.57	0.62	0.66	0.62	0.85	0.56	0.44	0.57	0.57	0.21	0.58	0.53	0.63	0.27	0.58	0.52	0.15	0.3	0.61	0.56	0.68	0.53	0.5		0.64
Common Stock Total Equity	0.88	0.91	0.73	0.85	0.81	0.85	0.91	-0.14	0.84	0.86	0.35	0.78	0.8	0.89	0.64	0.88	0.75	-0.26	0.81	0.89	0.75	0.86	0.84	0.83	0.64

Click cells to compare fundamentals

Bristol Myers Account Relationship Matchups

Bristol Myers balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	129.9B	118.5B	109.3B	96.8B	95.2B	99.9B
Short Long Term Debt Total	47.5B	51.7B	45.6B	40.7B	41.5B	43.5B
Other Current Liab	7.9B	10.2B	10.1B	13.1B	11.5B	12.1B
Total Current Liabilities	18.3B	19.1B	21.9B	21.9B	22.3B	23.4B
Total Stockholder Equity	51.6B	37.8B	35.9B	31.1B	29.4B	15.0B
Property Plant And Equipment Net	6.3B	6.7B	7.0B	7.5B	8.0B	5.2B
Net Debt	35.2B	37.1B	31.6B	31.6B	30B	31.5B
Retained Earnings	34.5B	21.3B	23.8B	25.5B	28.8B	22.0B
Cash	12.3B	14.5B	14.0B	9.1B	11.5B	12.0B
Non Current Assets Total	100.6B	88.3B	76.1B	69.5B	63.4B	66.6B
Non Currrent Assets Other	6.6B	2.1B	1.7B	1.0B	1.9B	2.0B
Cash And Short Term Investments	12.3B	14.5B	14.0B	9.1B	12.3B	12.9B
Net Receivables	7.7B	8.5B	12.5B	13.9B	15.3B	16.0B
Good Will	22.5B	20.5B	20.5B	21.1B	21.2B	22.2B
Common Stock Shares Outstanding	1.7B	2.3B	2.2B	2.1B	2.1B	1.6B
Liabilities And Stockholders Equity	129.9B	118.5B	109.3B	96.8B	95.2B	99.9B
Non Current Liabilities Total	59.9B	61.5B	51.4B	43.8B	43.4B	45.6B
Inventory	4.3B	2.1B	2.1B	2.3B	2.7B	1.9B
Other Current Assets	2.0B	1.4B	1.3B	1.6B	1.5B	1.8B
Other Stockholder Equity	18.4B	18.1B	13.1B	6.5B	1.9B	2.0B
Total Liab	78.2B	80.6B	73.3B	65.7B	65.7B	69.0B
Property Plant And Equipment Gross	6.3B	5.9B	11.0B	11.6B	12.8B	13.5B
Total Current Assets	29.4B	30.2B	33.3B	27.3B	31.8B	33.4B
Accumulated Other Comprehensive Income	(1.5B)	(1.8B)	(1.3B)	(1.3B)	(1.5B)	(1.6B)
Short Term Debt	3.5B	2.5B	5.1B	4.4B	3.3B	3.4B
Intangible Assets	64.0B	53.2B	42.8B	36.4B	27.5B	28.9B
Accounts Payable	2.4B	2.7B	2.9B	3.0B	3.3B	1.9B
Short Term Investments	3.0B	1.3B	3.2B	130M	816M	775.2M
Other Liab	15.9B	12.3B	11.0B	7.4B	8.5B	4.9B
Other Assets	4.8B	7.3B	3.3B	2.9B	3.3B	3.3B
Long Term Debt	43.4B	48.3B	39.6B	35.1B	36.7B	38.5B
Treasury Stock	(25.4B)	(26.2B)	(31.3B)	(38.6B)	(43.8B)	(41.6B)
Property Plant Equipment	6.3B	5.9B	6.0B	6.3B	7.2B	5.8B
Current Deferred Revenue	4.5B	3.6B	3.7B	1.3B	4.2B	4.4B
Net Tangible Assets	(34.9B)	(36.0B)	(28.2B)	(25.9B)	(23.4B)	(22.2B)
Noncontrolling Interest In Consolidated Entity	96M	100M	60M	57M	55M	74.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
V	Visa Class A
GM	General Motors

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bristol Historical Balance Sheet

Bristol Myers Inventory

1.86 Billion

About Bristol Balance Sheet Analysis

Bristol Myers Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Other Current Assets

Bristol Myers balance sheet Correlations

Bristol Myers Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bristol Myers balance sheet Accounts

Also Currently Popular

Additional Tools for Bristol Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total

Common Stock Shares Outstanding	- 0.62	Retained Earnings
Other Stockholder Equity	- 0.45	Retained Earnings
Other Current Assets	- 0.37	Cash And Short Term Investments
Other Current Assets	- 0.34	Common Stock Shares Outstanding
Other Stockholder Equity	- 0.33	Other Current Assets
Short Term Debt	- 0.32	Other Current Assets